connecT SYSTEMHAUS AG provides strategic IT management consulting, focusing on aligning IT strategies with business goals and enhancing IT security.

connecT SYSTEMHAUS AG

Bain & Company is an American management consulting firm that provides advice to public, private, and non-profit organizations. It offers a wide range of services including strategy, marketing, organization, operations, technology, digital solutions, advanced analytics, corporate finance, mergers & acquisitions, and sustainability across all industries and geographies.

Bill Bain

Dorte Bregnhøj

Hüseyin Binzat

Maurizio G Esentato

Bain & Company

Boston Consulting Group (BCG) is a global management consulting firm that partners with leaders in business and society to tackle their most important challenges and capture their greatest opportunities. BCG delivers solutions through leading-edge management consulting, technology and design, and corporate and digital ventures.

Jan Jamrich

Bruce Henderson

Boston Consulting Group

Booz Allen Hamilton Holding Corporation provides management and technology consulting, analytics, engineering, digital solutions, mission operations, and cyber services to governments, corporations, and not-for-profit organizations in the United States and internationally. The company offers consulting solutions for various domains, business strategies, human capital, and operations. It also provides analytics services, which focuses on delivering transformational solutions in the areas of artificial intelligence, such as machine learning and deep learning; data science, such as data engineering and predictive modeling; automation and decision analytics; and quantum computing. In addition, the company designs, develops, and implements solutions built on contemporary methodologies and modern architectures; delivers engineering services and solutions to define, develop, implement, sustain, and modernize complex physical systems; and provides cyber risk management solutions, such as prevention, detection, and cost effectiveness. Booz Allen Hamilton Holding Corporation was founded in 1914 and is headquartered in McLean, Virginia.

Edwin G. Booz

James L. Allen

Carl L. Hamilton

Booz Allen Hamilton Holding Corporation

Centro Nacional de Análisis Genómico (CNAG) | 10,205 followers on LinkedIn. Sequencing for a better life | The Centro Nacional de Análisis Genómico (CNAG)  is a national non-profit organisation, specialised in sequencing and genomic analysis, located in the Parc Científic de Barcelona. Its trajectory started in 2009, becoming the first national sequencing center and one of the most pioneering in Europe, founded by the Ministry of Science and the Generalitat de Catalunya. Its principal mission is developing genomic analysis projects with a high impact on improving people&#39;s health and quality of life, in collaboration with national and international health institutions and research centers.

Jordi Camps

McGill U. (BSc Hon, MSc) & U. of Manchester (MSc) alumnus. Berkeley Project Management. Certified in Nutrition (eCornell) and in Integrative…

Francisco C. Ferreira

Ivo Gut

Tyler Alioto

Centro Nacional de Análisis Genómico (CNAG)

💚 En el Día de las Enfermedades Neuromusculares, ¡nos hace mucha ilusión compartir esta noticia! 🏆 Pedro M Rodríguez Cruz , neurólogo y especialista en genómica clínica en CNAG, ha sido galardonado con el 'President's Prize for the Emerging Myologist of the Year' por su gran labor en la investigación de trastornos neuromusculares. 🔬Una de las contribuciones más importantes de Pedro es Senegene Project, una colaboración entre la Universidad de Dakar y CNAG cuyo objetivo es ofrecer diagnósticos a pacientes y familias con enfermedades neurogenéticas raras en Senegal. ¡Muchas felicidades, Pedro! https://lnkd.in/d5VXfUm7 #15N #DiaNacionalENM #Research #EnfermedadesNeuromusculares #Genomica #CNAG #SaludNeuromuscular #Investigación

⌛️Countdown to the 13th CNAG Symposium! 🧬Ready to be part of the genomics healthcare revolution? Discover the latest breakthroughs in cancer, rare diseases, autism, and much more! Don’t miss out! 🗓️Tuesday, Dec. 10 (09-17h) ⬇️Free registration https://lnkd.in/dn-v49qP #CNAGSymposium #PrecisionMedicine #CancerResearch #RareDiseaseResearch #AutismResearch #HealthcareInnovation

🙌 Exciting news! 🎖️ Tomas MARQUES BONET , principal investigator at CNAG, Institute of Evolutionary Biology (CSIC-Universitat Pompeu Fabra) , ICREA researcher and professor at Universitat Pompeu Fabra - Barcelona , has been appointed a new academic member of the Royal Spanish Academy of Sciences (RAC). Many congratulations, Tomàs! 📎 https://lnkd.in/dsSekds8 #RAC #raciencias #Research #Genomics #CNAG #IBE #UPF #ICREA Photo: Pilar Rodríguez Franco

📢 Great news! Our Director at CNAG, Ivo Gut , will be speaking at the Festival of Genomics and Biodata, taking place on the 29th-30th of January, 2025, at ExCeL London. If you want to learn more about how to share data internationally in a safe and efficient way, don’t miss it! ➡️ Registration is free for over 90% of attendees: https://lnkd.in/eX7u8Wrj #Genomics #CNAG #FOG2025 #Biodata #DataScience #HealthData

🔬✨ The CNAG Symposium is back! We are thrilled to announce the 13th CNAG Symposium on December 10th, focused on "Genomics translated into healthcare provision." 🧬 This year, we bring together leading experts to discuss how genomic research is transforming healthcare, advancing diagnostics, treatments, and personalised care. 📅 Date: December 10th 📍 Location: CNAG, Barcelona (in-person event) 🔗 Don’t miss it! Register now and find more details on our website: https://lnkd.in/dn-v49qP #Genomics #Healthcare #CNAGSymposium #HealthcareInnovation #GenomicResearch #Events #CNAG #GenomeResearch #Healtcare

🎀 On #BreastCancerDay , we want to highlight the importance of research in the fight against this diseases, the most common cancer among women At #CNAG , we participate in international and national projects focused in prevention, diagnosis and treatment #BreastCancerAwareness #EarlyDetectionSavesLives #CáncerDeMama #DíaContraElCáncerDeMama #SequencingForABetterLife #Genomics

📢 Exciting news! 🔝 Five of our researchers at CNAG have been recognized in the Stanford ranking 2024, which highlights the top 2% of researchers worldwide: - Ivo Gut , director of CNAG and Biomedical Group Leader - Holger Heyn , Single Cell Genomics Group Leader - Marc A. Marti-Renom , Structural Genomics Group Leader - Simon Heath , Bioinformatics Development and Statistical Genomics Team Leader - Tyler Alioto , Genome Assembly and Annotation Team Leader Really proud of their outstanding contributions to the field of genomics and biomedical research. Many congratulations! 👏 📎 https://lnkd.in/gp2fggdH #CNAG #StanfordRanking #ResearchExcellence #Top2Percent #Genomics #BiomedicalResearch

📹 ¡Nuevo reportaje sobre #CNAG ! 🧬 ¿Te gustaría saber cómo analizamos el ADN, paso a paso? 🔝 Esta vez, te lo cuenta Leo Olivares de Ciencia Radiactiva Un estudiante de bachillerato que promueve la divulgación científica en sus redes sociales, y que ya cuenta con más de 460K followers En la visita, lo acompaña nuestro Laboratory Engineer Javier Gutiérrez Cuesta , de la Unidad de Secuenciación ▶️ https://lnkd.in/dhPcTzZD #CienciaParaTodos #Genómica #Divulgación #ICTS #HablemosDeCiencia #TalentoJoven #Salud #Investigación

🚀 New biomedical research on Small Cell Lung Cancer (SCLC)! 🫁 Did you know that this type of lung cancer is one of the least known and most aggressive? 🔬 We are focusing on the biological characterisation of SCLC and its microenvironment to uncover tumor vulnerabilities and resistance mechanisms. Our objective is to improve therapeutic strategies that will provide a solid foundation for clinical testing Led by Pedro Rocha , researcher in our Single Cell Genomics Group at #CNAG , with the support of Asociación Española Contra el Cáncer and Fundación Científica de la Asociación Española Contra el Cáncer 📎 https://lnkd.in/da7pKHzz #MedicalResearch #SCLC #LungCancer #Genomics #TodosContraelCancer #CancerResearch #SCLC #PrecisionMedicine #SingleCellGenomics #AECC #ImmunoOncology

🚀 New biomedical research on Colorectal Cancer, DYNAMITE! 👩🔬 Excited to announce that our Spatial Genomics Team Leader at #CNAG , Anna Pascual Reguant , will lead this research to enhance the success of immune checkpoint inhibition therapy in colorectal cancer by developing a novel class of predictive biomarkers. A major research challenge that can improve the health of many patients! https://lnkd.in/dx6jXrzR ➡️ Project PID2023-148687OB-I00, funded by the MCIN/AEI/10.13039/501100011033/FEDER/UE #FEDER #AEI Ministerio de Ciencia, Innovación y Universidades #EuropeanUnion #MedicalResearch #ColorectalCancer #Genomics

Metric
Company Name	connecT SYSTEMHAUS AG	Bain & Company	Boston Consulting Group	Booz Allen Hamilton Holding Corporation
Symbol				BAH
MSH ID	DE:CNAG	COM:BAIN	COM:BCG	COM:BOOZALLEN
Market	PRIVATE	PRIVATE	PRIVATE	STOCKS
Sector	Technology	Commercial & Professional Services	Commercial & Professional Services	Industrials
Industry	Information Technology	Management Consulting	Business Consulting and Services	Consulting Services
Country	DE	US	US	US
Stage
Employee Count		21.73K	35.34K	34.20K
Website	cnag.de	bain.com	bcg.com	boozallen.com
LinkedIn	centro-nacional-de-analisis-genomico	bain-and-company	boston-consulting-group
Founders

Metric
Market Cap		20.15B
Enterprise Value
Monthly Web Traffic	7.96K	402.37K
Web Traffic Growth	-0.23	-0.21
Valuation
Raised Capital		650M

Metric
Revenue				10.66B
Revenue (LTM)
Revenue (NTM)
Gross Profit				2.29B
EBITDA				1.19B
Operating Income				1.02B
Net Income				605.71M
EPS				4.61
Diluted EPS				4.59
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin				0.54
Operating Profit Margin				0.10
EBITDA Margin				0.11
Net Profit Margin				0.06
Return on Equity				0.57
Return on Assets				0.09
Return on Capital Employed				0.21

CNAG

DE:CNAG

connecT SYSTEMHAUS AG

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio				45.24
P/B Ratio				17.05
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio				1.95
EV Multiple				24.13

Metric
Days Sales Outstanding				69.58
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle				76.06
Cash Conversion Cycle				41.10
Asset Turnover				1.65

Metric
Operating Cash Flow				258.84M
Free Cash Flow				192.14M
Cash Flow to Debt				0.11
Operating Cash Flow/Sales				0.03
Free Cash Flow Yield				0.01

Metric
Cash & Equivalents				554.26M
Accounts Receivable				-269.64M
Inventory				-8.71M
Goodwill				2.34B
Debt to Capitalization				0.77
Debt to Assets				0.56
Current Ratio				1.68
Quick Ratio				1.62

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue				0.01
R&D to Revenue
SG&A to Revenue				0.42